204 related articles for article (PubMed ID: 9109227)
1. The role of surgery in the multimodality management of non-small cell lung cancer.
Kaiser LR; Friedberg JS
Semin Thorac Cardiovasc Surg; 1997 Jan; 9(1):60-79. PubMed ID: 9109227
[TBL] [Abstract][Full Text] [Related]
2. [Multimodal treatment of non small cell lung cancer].
Stoelben E; Digel W; Henke M; Passlick B
Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776
[TBL] [Abstract][Full Text] [Related]
3. Is lobe-specific lymph node dissection appropriate in lung cancer patients undergoing routine mediastinoscopy?
Turna A; Solak O; Kilicgun A; Metin M; Sayar A; Gürses A
Thorac Cardiovasc Surg; 2007 Mar; 55(2):112-9. PubMed ID: 17377865
[TBL] [Abstract][Full Text] [Related]
4. [Surgical therapeutic strategy for non-small cell lung cancer with (N2) mediastinal lymph node metastasis].
Huang GJ; Fang DK; Cheng GY; Zhang DC
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):62-4. PubMed ID: 16737625
[TBL] [Abstract][Full Text] [Related]
5. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.
Lardinois D; Suter H; Hakki H; Rousson V; Betticher D; Ris HB
Ann Thorac Surg; 2005 Jul; 80(1):268-74; discussion 274-5. PubMed ID: 15975380
[TBL] [Abstract][Full Text] [Related]
6. The role of multimodality therapy in locoregional non-small cell lung cancer.
Martini N; Kris MG; Ginsberg RJ
Surg Oncol Clin N Am; 1997 Oct; 6(4):769-91. PubMed ID: 9309093
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
[TBL] [Abstract][Full Text] [Related]
8. Postrecurrence survival in patients with stage I non-small cell lung cancer.
Nakagawa T; Okumura N; Ohata K; Igai H; Matsuoka T; Kameyama K
Eur J Cardiothorac Surg; 2008 Sep; 34(3):499-504. PubMed ID: 18579404
[TBL] [Abstract][Full Text] [Related]
9. Surgical assessment and intraoperative management of mediastinal lymph nodes in non-small cell lung cancer.
Whitson BA; Groth SS; Maddaus MA
Ann Thorac Surg; 2007 Sep; 84(3):1059-65. PubMed ID: 17720443
[TBL] [Abstract][Full Text] [Related]
10. [Combination of mediastinal lymph node excision and thoracoscopic pneumonectomy for a case of N2 lung cancer confirmed by mediastinoscopy].
Ike O; Okubo K; Bando T; Tanaka F; Hirata T; Fukuse T; Mizuno H; Wada H; Hitomi S
Jpn J Thorac Cardiovasc Surg; 1998 Apr; 46 Suppl():163-4. PubMed ID: 9642831
[No Abstract] [Full Text] [Related]
11. [Value and limits of conventional mediastinoscopy in preoperative evaluation of primary bronchial cancer].
Robert J; Rochat T; Savioz D; Ludwig C; Spiliopoulos A
Schweiz Med Wochenschr; 1998 Jun; 128(23):895-9. PubMed ID: 9658517
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer.
Meyers BF; Haddad F; Siegel BA; Zoole JB; Battafarano RJ; Veeramachaneni N; Cooper JD; Patterson GA
J Thorac Cardiovasc Surg; 2006 Apr; 131(4):822-9; discussion 822-9. PubMed ID: 16580440
[TBL] [Abstract][Full Text] [Related]
13. Frequency of noncontiguous lymph node involvement in patients with resectable nonsmall cell lung carcinoma.
Bonner JA; Garces YI; Sawyer TE; Gould PM; Foote RL; Deschamps C; Lange CM; Li H
Cancer; 1999 Oct; 86(7):1159-64. PubMed ID: 10506699
[TBL] [Abstract][Full Text] [Related]
14. Surgical approach to non-small cell lung cancer stage IIIA.
Martini N; Ginsberg RJ
Hematol Oncol Clin North Am; 1990 Dec; 4(6):1121-31. PubMed ID: 1962779
[TBL] [Abstract][Full Text] [Related]
15. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved.
Matsuguma H; Nakahara R; Ishikawa Y; Suzuki H; Inoue K; Katano S; Yokoi K
Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):573-7. PubMed ID: 18413349
[TBL] [Abstract][Full Text] [Related]
16. Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer.
Cerfolio RJ; Bryant AS
Ann Thorac Surg; 2008 Aug; 86(2):362-6; discussion 366-7. PubMed ID: 18640297
[TBL] [Abstract][Full Text] [Related]
17. [State of the art treatment of lung cancer: non-small cell lung cancer--surgical treatment].
Asamura H
Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():366-72. PubMed ID: 9369909
[TBL] [Abstract][Full Text] [Related]
18. [Local recurrence in complete resection for non-small cell lung cancer].
Ohta S; Inaba H; Hirose M; Syundou Y
Kyobu Geka; 2000 Mar; 53(3):185-9. PubMed ID: 10714104
[TBL] [Abstract][Full Text] [Related]
19. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP
Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
[TBL] [Abstract][Full Text] [Related]
20. Thoracoscopic lobectomy with systemic lymph node dissection for lymph node positive non-small cell lung cancer--is thoracoscopic lymph node dissection feasible?
Shiraishi T; Hiratsuka M; Yoshinaga Y; Yamamoto S; Iwasaki A; Shirakusa T
Thorac Cardiovasc Surg; 2008 Apr; 56(3):162-6. PubMed ID: 18365976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
